BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180428
DTEND;VALUE=DATE:20180908
DTSTAMP:20260823T072202
CREATED:20180428T131558Z
LAST-MODIFIED:20180428T131558Z
UID:19962-1524873600-1536364799@ces.b2sg.org
SUMMARY:Postdoc Research Associate
DESCRIPTION:This position will employ a wide range of experimental systems and interdisciplinary approaches and provide broad training in 3 areas: a.) control of cell cycle and tumor suppression by the ubiquitin pathway\, b.) tumor metabolism\, and c.) epigenetic control during tumorigenesis and innate immunity with an emphasis on the regulation of DNA de/methylation. The incumbent will be employed to carry out advanced independent and/or directed research to achieve the objectives of the research project. The principal investigator will establish the professional objectives and performance standards for the incumbent and will make annual evaluations. \n\n\n\n\nMinimum Qualifications: \nThis position requires knowledge of the fields\, processes and disciplines of cell biology and cancer metabolism. The position will involve organizing and implementing research plans\, the development of methods of research\, testing and data collection\, analysis and evaluation\, and writing reports containing descriptive\, analytical and evaluative content. The duties require discretion and judgement in carrying out research activities within the predetermined research scope and methodology. A PhD degree in the appropriate biomedical science or related field or discipline\, or the recognized terminal degree\, is required.
URL:https://ces.b2sg.org/event/unc-28apr18/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180512
DTEND;VALUE=DATE:20180614
DTSTAMP:20260823T072202
CREATED:20180512T084407Z
LAST-MODIFIED:20180512T181333Z
UID:20054-1526083200-1528934399@ces.b2sg.org
SUMMARY:Research Scientist
DESCRIPTION:RESEARCH SCIENTIST\, Koch Institute (KI) for Integrative Cancer Research-J&J Lung Cancer Initiative Collaboration. \n\nJob Requirements\nREQUIRED: MD and/or Ph.D. in medicine and/or biomedical science; extensive knowledge of cancer biology and related fields; ability to conceptualize and write proposals and publishable manuscripts\, evaluate and train junior researchers\, innovate\, and conduct research; meticulous attention to detail; strong organizational\, documentation\, interpersonal\, and communication skills; comfort summarizing and reporting results; ability to work collaboratively\, follow safety procedures\, and maintain a safe work environment. Familiarity with physiology; cell and molecular biology; immunology; animal testing of biologics; materials science; and/or histological\, biochemical\, and mechanical analyses ideal. Job #15547 \nThis is a one-year\, term-limit appointment with an extension based on continued funding.
URL:https://ces.b2sg.org/event/ki-12may18/
LOCATION:Koch Institute MIT\, Cambridge\, MA\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/01/Koch-mit-e1515928148181.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180512
DTEND;VALUE=DATE:20180614
DTSTAMP:20260823T072202
CREATED:20180512T174404Z
LAST-MODIFIED:20180512T180657Z
UID:20057-1526083200-1528934399@ces.b2sg.org
SUMMARY:Post Doctoral Research Associate
DESCRIPTION:We are seeking a motivated Postdoctoral Scientist or Research Assistant Professor interested in advancing his or her career in a vibrant and highly collaborative environment to join an interdisciplinary team at the Huntsman Cancer Institute. \nDr. Ulrich is a Senior Director for Population Sciences at the Huntsman Cancer Institute and has research projects available in cancer prognosis\, molecular diagnostics\, and survivorship of colorectal cancer. \nThe University/Huntsman Cancer Institute is home to exceptional genetic epidemiologic resources\, including the Utah Population Database\, with >9 million records\, including extensive Utah genealogy records linked to the Utah SEER Cancer Registry\, as well as health records from the University of Utah Hospital and Clinics\, links to statewide cancer and other statewide health record database resources. The University’s excellent biostatistics and research design\, genomics resources\, and biospecimen repository\, as well as a strong research informatics core\, enable outstanding research in genetic and molecular epidemiology. Our Cancer Hospital provides superb resources for multidisciplinary collaborations in translational/clinical epidemiology. HCI is a NCI-designated comprehensive cancer center which supports a vibrant research enterprise in a highly collegial environment. We are currently doubling our research space and increasing our faculty in population sciences research. \nUtah is known for stunning natural wonders\, including 5 National Parks\, and world-class recreation for outdoor enthusiasts. Salt Lake City and the surrounding areas offer diverse neighborhoods\, great schools\, restaurants\, arts and entertainment\, and endless possibilities for sports and recreation. Learn more at: http://healthsciences.utah.edu/living_in_utah/index.php. \nThe University of Utah Health Sciences Center is a patient focused center distinguished by collaboration\, excellence\, leadership\, and Respect. The University of Utah HSC values candidates who are committed to fostering and furthering the culture of compassion\, collaboration\, innovation\, accountability\, diversity\, integrity\, quality\, and trust that is integral to the mission of the University of Utah Health Sciences Center. \nResponsibilities \nOur research includes transdisciplinary approaches to colorectal cancer prognosis\, utilizing health behavior information as well as metabolomics\, proteomics\, epigenetics and other molecular diagnostics. The position will involve participation in international consortia (GAME-ON\, CORECT\, ColoCare\, NIH-COMET)\, statistical analyses\, leadership on multiple publications\, project management\, and active participation in grant applications. \nMinimum Qualifications \n\nA doctoral degree in molecular & translational epidemiology or equivalent (Epidemiology\, Statistics\, Biostatistics\, Genetics\, Nutritional Sciences\, Pharmacology or Medicine)\nExcellent writing and communication skills and a solid publication record\nKnowledge of epidemiology and biostatistics\nHighly motivated\, organized and intelligent\nTeam player able to work with scientists of diverse backgrounds\n\nPreferences \n\nBackground in colorectal cancer preferred\n\n\nFor Research Assistant Professor: 2 years of postdoctoral experience\n\n\nThe HCI is growing substantially and also offers perspectives for tenured faculty positions.\n\nType Benefited Staff Special Instructions Summary \nInterested? Please contact Dr. Neli Ulrich\, neli.ulrich@hci.utah.edu\nCheck out our websites at: http://www.huntsmancancer.org/ulrich and https://healthcare.utah.edu/huntsmancancerinstitute/research/research-studies/colocare-consortium.php \nHCI is growing substantially and also offers perspectives for tenured faculty positions.
URL:https://ces.b2sg.org/event/utah-12may18/
LOCATION:University of Utah\, 201 Presidents Cir\, Salt Lake City\, 84112\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/university-of-utah_416x416.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180515
DTEND;VALUE=DATE:20180617
DTSTAMP:20260823T072202
CREATED:20180515T175215Z
LAST-MODIFIED:20180515T175215Z
UID:20083-1526342400-1529193599@ces.b2sg.org
SUMMARY:Postdoctoral Scientist
DESCRIPTION:The Department of Biochemistry and Molecular Medicine (BMM) strives to deliver the highest quality of professional education and training\, and conduct cutting edge research in the areas of biochemistry\, molecular genetics and genomics with a goal to better understand human disease. Additionally\, the department continues to have a long and successful record in training undergraduate\, master and graduate students at the George Washington University School of Medicine and Health Sciences. \nOur Research Programs span from cancer biology\, hepatobiology\, autism\, vascular biology\, and computational genomics. Unlocking the mysteries of biologic processes at the molecular and genomic level is the common thread connecting all research programs. The overall research in the department continues to connect modern biochemistry and genomic discoveries to translational medicine\, leading to a unique multidisciplinary research program in biochemistry and molecular medicine. Find out more here: https://smhs.gwu.edu/biochemistry/ \nThe Biochemistry and Molecular Medicine department is looking for a candidate that will work under the direct supervision of Dr. Mei-Yi Wu. He or she will be responsible for carrying out the research experiments. He or she will also participate in the weekly lab meeting\, and present and discuss the progress of the project with Dr. Mei-Yi Wu. \nThe project focuses on two epigenetic modulators and members of the AT-rich interaction domain family\, ARID4A and ARID4B. Epigenetics plays an important role in human health and disease. Disruption of epigenetic modifications leads to dysregulation of gene function without altering the DNA sequence per se. A major challenge in understanding the importance of epigenetics in human health and diseases is to identify the specific epigenetic factors and the signaling involved. Currently\, we are investigating the role of ARID4A and ARID4B in development and cancer disease using state-of-the-art conditional knockout mouse models and genomic and proteomic approach. We also study the role of ARID4B in cancer stem cells that have been suggested as the major cause for therapy resistance and the driving force behind cancer metastasis and relapse. To investigate whether and how ARID4B drive cancer development\, we evalute the underlying molecular mechanisms by which ARID4B promotes therapy resistance and aggressive cancer. \nDuties include: \n\nCulture and transfection of mammial cells\nCollecting samples for reporter gene assays\nWestern blotting to analyze protein expression\nCancer cell migration and invasion assays\nHuman cancer xenogrant experiments using SCID/NOD mice\nThe postdoc will also work with genetically modified mice\nOrdering lab supplies\, lab maintenance and other duties as assigned\nThis position performs other duties as assigned. The omission of specific duties does not preclude the supervisor from assigning duties that are logically related to the position.\n\n\nMinimum Qualifications: \nQualified candidates will hold a PhD in a related discipline. Degree must be conferred by the start date of the position \nAdditional Required Licenses/Certifications/Posting Specific Minimum Qualifications: Preferred Qualifications: \nPh.D. degree\, with experience in molecular and cellular biology.
URL:https://ces.b2sg.org/event/gwu-15may18/
LOCATION:George Washington University\, 2121 I St NW\, Washington\, DC\, 20052\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/gwu-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180516
DTEND;VALUE=DATE:20180618
DTSTAMP:20260823T072202
CREATED:20180516T094155Z
LAST-MODIFIED:20180516T094942Z
UID:20091-1526428800-1529279999@ces.b2sg.org
SUMMARY:Associate Researcher - Oncological Sciences
DESCRIPTION:Dr. Amaia Lujambio´s research group studies mechanisms of liver cancer initiation and liver cancer maintenance. In particular\, we are interested in how genetic alterations in cancer cells contribute to tumorigenesis\, alter treatment response\, and create vulnerabilities that may be targeted therapeutically. In particular\, we are interested in understanding how genetic alterations in liver cancer cells affect mechanisms of immune escape and response to immunotherapies. \n \nOur research interests involve the establishment of in vitro and in vivo systems for the study of liver cancer\, as well as the rational use of shRNA and CRISPR libraries to identify drug targets for the disease. We utilize sophisticated mouse models of cancer\, RNAi and CRISPR technologies\, valuable human cancer samples\, and genetic and epigenetic profiling as key tools. \n \nThe ultimate goal is to improve our understanding of liver cancer and to identify novel strategies that can be exploited therapeutically to improve healthspan and longevity. \n \n \nRequirements:\n\nBachelor of Science in molecular biology\, cell biology\, immunology or a related topic\nThe candidate will be expected to work well in a collaborative environment\, and to have strong communication skills\nExperience in molecular biology\, cell culture\, flow cytometry is required. Computational skills\, immunology and mouse experience are a plus
URL:https://ces.b2sg.org/event/sinai-16may18/
LOCATION:Mount Sinai – Icahn School of Medicine\, 1468 Madison Ave\, New York\, NY\, 10029\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/mount-sinai.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180518
DTEND;VALUE=DATE:20180620
DTSTAMP:20260823T072202
CREATED:20180518T090019Z
LAST-MODIFIED:20180522T120337Z
UID:20099-1526601600-1529452799@ces.b2sg.org
SUMMARY:Principal Scientist - Cancer Epigenetics
DESCRIPTION:Pfizer Oncology Research & Development (ORD) in La Jolla\, California\, is seeking a Principal Scientist focused on translating basic discoveries in the field of cancer epigenetics into novel therapeutics. \nOur ideal candidate will lead a team of motivated and scientifically rigorous scientists to perform laboratory-based research in a collaborative team environment. The candidate will lead biological target validation\, utilizing genetic and pharmacological approaches to discover and confirm candidates for novel cancer therapeutics. As a member of the group\, you will also be involved in mechanism-of-action studies\, interpretation and presentation of data\, and will function as an integral member of the team to advance new targets. The successful candidate will have experience in the integration of molecular profiling data including epigenomic (ATAC-seq\, ChIP-seq)\, transcriptomic\, proteomic\, and genomic datasets\, into a broader understanding of epigenetic regulation within the tumor and interactions between the tumor and the tumor microenvironment. \nRole Responsibilities \n\nLead a laboratory research group to study genetic and epigenetic mechanisms in tumor biology with the aim to identify new therapeutic targets that can be translated to the clinic\nUtilize expertise in epigenetic biology to design\, execute\, and analyze/interpret innovative approaches for epigenetic targeting in cancer.\nWork collaboratively with computational biology group to integrate complex data sets including epigenomic and other ‘omic’ data in pre-clinical settings for target discovery\, validation\, and advance mechanism of action target biology\nLead development of cell and molecular assays to define mechanism of action\, measure pharmacodynamic changes and select responder patient populations.\nInterface with discovery biology and computational biology groups to design\, develop\, and interpret datasets developed from genetic and pharmacological screens\nDevelop and apply complex in vitro assays including organoids to enable target discovery\, validation and drug development.\nProactively seek out new information in the literature and incorporate this into individual project(s) as well as the overall program.\nPresent research results and methodologies at weekly meetings with immediate supervisor and/or project leader\, and at meetings with members of the oncology research unit as appropriate.\nContribute to building a culture that embraces scientific excellence\, urgency\, partnerships with key stakeholders\, continuous learning and improvement\, increasing technical skill base and cancer biology expertise; take a proactive role in personal growth and scientific development.\n\nBasic Qualifications \n\nPhD in Molecular Biology\, Pharmacology (or a comparable biological science) plus post doc and 4+ years of relevant experience in an academic or pharmaceutical/biotech environment.\nExpertise in chromatin biology\, epigenetics and mechanism of transcriptional regulation as evidenced by publication in peer-reviewed journals.\nExtensive knowledge and experience in areas of tumor biology including\, but not limited to immune oncology\, oncogenic signaling\, cancer metabolism\, apoptosis and/or DNA damage and repair\nDemonstrate proficiency in the use of software tools to support epigenomic data analysis including ATAC-seq\, ChIP-seq\, and RNA-seq.\nExperience in use of CRISPR-based techniques for gene knockout\, gene editing and as well as working knowledge of pooled CRISPR -based screening approaches\nAble to work in a team environment\, good communication skills and excellent leaderships skills.\nExperience managing scientists\n\nPreferred Qualifications \n\nPreference for candidates with a strong track record in cancer drug discovery and the targeting of epigenetic pathways by small-molecule inhibitors.
URL:https://ces.b2sg.org/event/pfizer-18may18/
LOCATION:Pfizer – Pearl River\, NY\, 401 North Middletown Road\, Pearl River\, NY\, 10965\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/pfizer_new_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180519
DTEND;VALUE=DATE:20180715
DTSTAMP:20260823T072202
CREATED:20180519T171048Z
LAST-MODIFIED:20180519T171231Z
UID:20115-1526688000-1531612799@ces.b2sg.org
SUMMARY:Postdoctoral Associate
DESCRIPTION:An exciting opportunity is available to join a cancer pharmacology lab that emphasizes pharmacokinetic (PK)\, pharmacodynamic (PD)\, and quantitative systems pharmacology (QSP) approaches to study brain tumors. The lab integrates experimental data with mathematical models or QSP models to characterize drug action and predict drug responses in patients. The ultimate goal is to bridge preclinical and clinical drug development paradigms and advance precision medicine. \nThe postdoctoral position is in the lab of James M. Gallo in the Department of Pharmaceutical Sciences\, School of Pharmacy and Pharmaceutical Sciences at the University at Buffalo. The department is a premier research unit with a storied tradition of excellence in PK/PD research. Ongoing projects are in anticancer drug development\, drug resistance\, cell state\, epigenetics and tumor heterogeneity. \nThe postdoctoral associate will join a highly interactive department with a central focus of PK/PD/QSP modeling\, and have opportunities to interact with highly talented graduate students\, and scientists within the university including Roswell Park Cancer Institute. Position responsibilities include: \n\nDevelop PK/PD/QSP models using a variety of computer programs.\nParticipate in lab meetings and contribute to the training of students and lab personnel in advanced modeling methods.\nInteract positively with scientific personnel across different disciplines to advance QSP.\nProvide expert support of computer systems used for the labs modeling efforts.\nMaintain abreast of current literature in the fields relevant to lab projects.\nProvide reports based on your work for scientific publications and extramural funding applications.\nAdvance your knowledge of QSP modeling methods and implement those as needed\n\n\n\n\nMinimum Qualifications\n\n\nPh.D. in Engineering\, Mathematics\, Pharmacometrics\, Systems Biology/Pharmacology or a related field.\nDemonstration of mathematical modeling & computer simulation experience; preferably related to biomedical/pharmaceutical applications.\nExpertise in Matlab/SimBiology/Simulink.\nAdditional familiarity with R\, JDesigner/Systems Biology Workbench and related programs desirable.
URL:https://ces.b2sg.org/event/buffalo-19may18/
LOCATION:University at Buffalo\, Buffalo\, NY\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/ub-uni-at-buffalo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180520
DTEND;VALUE=DATE:20180622
DTSTAMP:20260823T072202
CREATED:20180520T133216Z
LAST-MODIFIED:20180520T133216Z
UID:20129-1526774400-1529625599@ces.b2sg.org
SUMMARY:Research Associate- General Surgery
DESCRIPTION:Job Summary/Essential Job Functions:  Under the direction of the Principal Investigator\, the Research Associate will work independently and perform assigned research.  This position requires strong knowledge of biomedical science\, processing of samples for cellular studies\, including cell sorting\, immunophenotyping\, cell culture\, establishing and keeping mice models for validation of identified pathway\, among other laboratory techniques.  This position will also manage\, designs and carries out experiments\, analyzes\, interprets and present data analyses and interpretation \n  \nDUTIES AND RESPONSIBILITIES:\n \n\nPreparation of samples for cellular studies\, data analyses\, and interpretation.\nPerform cellular/immunological study design.\nPerforms research experiments focused on understanding the role of Id3 in local B cell immune responses before and during liver ischemia reperfusion injury and disease development.\nPerforms Epigenetics ischemia reperfusion injury experimental procedures.\nPerforms experiments related to liver donor quality and mechanistic studies in liver cancer.\n Studies mechanistic chronic kidney disease.\nResearches and develops strategies to minimize ischemia reperfusion injury and pump perfusion.\nMaintain liver biorepository collections of samples.\nDocument experimental processes and results for preparation of scientific reports.\nWorks in conjunction with the PI in preparation of manuscripts\, grants and research compliance documents.\nSubmits published papers and obtain grant funding.\nPerform other duties as required.  \n\n \n \n  \nJOB SPECIFICATIONS:\n\nPh.D. Biological Science; four (4) years cell biology\, molecular biology\, biochemistry techniques; including cell culture\, molecular biology techniques.  The ability to prioritize and coordinate activities of the lab. Laboratory experience\, ability to maintain confidentiality and make sound independent judgments\, excellent verbal/written communication and leadership skills.  Working knowledge of databases\, spreadsheets\, word processing and other special programs for data analysis.  
URL:https://ces.b2sg.org/event/utnhsc-20may18/
LOCATION:University of Tennessee Health Science Center\, Memphis\, TN\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/uthsc-uni-tennessee.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180520
DTEND;VALUE=DATE:20180622
DTSTAMP:20260823T072202
CREATED:20180520T141606Z
LAST-MODIFIED:20180520T141606Z
UID:20133-1526774400-1529625599@ces.b2sg.org
SUMMARY:Postdoctoral Research Fellow
DESCRIPTION:The Thyroid Cancer Research Laboratory at MGH studies key genetic and epigenetic changes in those thyroid cancer patients who do poorly. We are seeking an experienced research fellow interested in pursuing innovative studies on pre-clinical mouse models of thyroid cancer and has an established interest and skillset that includes tumor immunology\, an understanding of mouse models of malignancy and a basic understanding of bio-informatics. \n\nPrincipal Duties & Responsibilities: The Research Fellow will join a collaborative group of scientists with expertise in studying the basic and translational biology of thyroid cancer. The research aims are to characterize the genetic changes in thyroid cancer that leads to proliferative\, immune and stromal alterations. This position provides outstanding opportunities for continued scientific development and for contributing to pioneering research with high translational impact. The scientific environment at MGH and surrounding institutions offers ample opportunity for productive collaborations. \n  \nJob Requirements: The candidate will have a solid foundation in experimental research with a strong record of publication. A PhD or MD/PhD degree is required. Expertise in molecular and immune cell biology is necessary. Experience working with rodents and immune assays as well the ability to work independently is preferred. Fundamental knowledge of signaling pathways\, tumor immunology and bioinformatics is important. Outstanding oral and written communication skills are important as well as willingness to work with collaborators and train students and residents. Those with a history of successful grant writing experience will be given preference. \n\nAdditional Information: Please include a cover letter with your resume which details your interests in thyroid cancer and 2-3 names of people who could immediately provide letters of reference. \n\nTo apply for this position\, please email or send your resume to: \nSareh Parangi\, MD \nProfessor of Surgery\, Harvard Medical School \n15 Parkman Street\, Wang 460\, Boston\, MA 02114 \nsparangi@mgh.harvard.edu
URL:https://ces.b2sg.org/event/mgh-20may18/
LOCATION:Massachusetts General Hospital Cancer Cente\, 55 Fruit St\, Boston\, MA\, 02114\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/mgh-massachusetts-general-hospital-cancer-center.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180520
DTEND;VALUE=DATE:20180622
DTSTAMP:20260823T072202
CREATED:20180520T172022Z
LAST-MODIFIED:20180520T172022Z
UID:20139-1526774400-1529625599@ces.b2sg.org
SUMMARY:Postdoc Research Fellow - Oncogenesis
DESCRIPTION:The Hackensack Meridian Health Center for Discovery and Innovation is offering a position for postdoctoral studies in the field of cancer signaling and gene expression in the laboratory of Dr. Byungwoo Ryu. The goal of the laboratory’s research program is to unravel the cancer epigenome regulating mechanisms which can be targeted for the sensitization to the precision therapies in the hope of translating these therapeutic modalities to have long-term clinical benefit. The Ryu laboratory focuses on investigating chromatin remodeling enzymes\, such as histone and DNA modifiers and gene transcription factors as potential targets for overcoming the resistance of oncogene-targeting therapies and enhancing the objective therapy response rate of immune check-point blockade therapies. The Ryu laboratory uses chemical genetics approaches including small molecule inhibitors\, genome/epigenome-wide profiling\, gene-editing technology\, and animal models. Successful postdoctoral candidate will have a strong interest in cancer biology\, epigenetics\, and immuno-oncology. The candidate will perform in vivo animal models and in vitro analyses. The postdoctoral fellow is expected to understand the project and work independently taking responsibilities in the development and execution of experimental procedures to successfully advance the research project. The successful candidate will be responsible for preparing data for presentations\, progress reports\, and the preparation of manuscripts and posters. The post-doctoral fellow is anticipated to have good communication and writing skills. The successful candidate will have a team-oriented mindset and will provide guidance to junior members. \n\n\n\nResponsibilities\n\n\n\n1. Proficient at most gold standard assays in molecular biology and genetics. 2. Design and conduct animal studies using a vast array of genetic models. 3. Perform data analysis and interpretation. 4. Present results in internal and external research forums. 5. Participate in grant and manuscript writing\, as appropriate. \n\n\n\nQualifications\n\n\n\nEducation\, Knowledge\, Skills and Abilities Required: 1. Hold a Ph.D. in Molecular Biology\, Biochemistry\, Cancer biology or equivalent from an accredited graduate level institution. 2. Minimum publication or in preparation of one article as first author in a reputable peer-reviewed scientific journal. 3. Excellent analytical and presentation skills. 4. Expertise in cell culture\, flow cytometry\, mouse handling\, and basic cellular and molecular biology techniques required. Education\, Knowledge\, Skills and Abilities Preferred: 1. Knowledge and experience with RNA/DNA extraction\, PCR and qPCR analysis\, and next generation sequencing/bioinformatics a plus. 
URL:https://ces.b2sg.org/event/hackensack-20may18/
LOCATION:Hackensack Meridian Health\, Hackensack\, NJ\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2018/05/hackensack-hackensackmeridianhealthlogo@2x.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180521
DTEND;VALUE=DATE:20180623
DTSTAMP:20260823T072202
CREATED:20180521T065023Z
LAST-MODIFIED:20180521T065830Z
UID:20145-1526860800-1529711999@ces.b2sg.org
SUMMARY:Senior Scientist-In Vivo Pharmacology Oncology
DESCRIPTION:We seek an accomplished Senior Scientist level oncologist/immunologist to join the in vivo pharmacology group within the Oncology Research Unit (ORU) of Pfizer’s Worldwide Research & Development (WRD) division in La Jolla\, California. The successful candidate will join a dynamic team of scientists in the Oncology In Vivo Pharmacology Group\, playing a leading role in the characterization of models of cancer and evaluating new drug candidates. \nParticipate in pre-clinical drug discovery and development projects with a focus on targeted therapeutics\, epigenetics and the tumor microenvironment. Characterize and develop small molecules in close collaboration with partner lines as an integral member of drug discovery teams. Evaluate anti-tumor effects in combination with biologics. Employ and develop new cutting-edge in vivo mouse and human cancer models. Provide technical and scientific expertise in in vivo pharmacology to the tumor cell biology department to enable target identification\, validation\, prioritization and efficient drug discovery of small molecules. \nThe candidate must have a strong background in immunology with extensive hands-on experience in multi-parameter flow cytometry analysis of tumor infiltrating immune cells (Fortessa-X20\, Cytobank\, FlowJo\, FACS\, MACS). \nIdeal applicants will have excellent communication\, leadership and organizational skills\, critical problem-solving abilities\, and a commitment to excellence.  \nROLE RESPONSIBILITIES \n\nPlan\, execute and analyze multi-parameter flow cytometric analysis studies of cells within the tumor microenvironment.\nResponsible for building and continuously updating flow panels based on recent scientific advances. Maintenance and upgrade of equipment (Fortessa-X20).\nDevelop and characterize new in vivo mouse models\, including syngeneic tumor and genetically engineered mouse (GEM) models\, to study biologic mechanisms and support exploration of novel therapies.\nDesign and conduct in vivo studies to evaluate and establish efficacy\, PK/PD relationship\, combination strategy\, biomarker identification and analysis.\nInterpretation\, presentation and documentation of experiments as well as preparation of reports.\nWritten and verbal presentation of results within a multidisciplinary team environment.\nPublication of results in scientific peer-reviewed journals and presentations at internal\, national\, and international meetings.\nMay manage a colleague\n\nBASIC QUALIFICATIONS \n\nPh.D. (or M.S. degree with 7+ years’\, or B.S. degree with 10+ years’\, relevant post-graduate experience) in Cancer Biology\, Immunology or related discipline.\nExtensive expertise in multi-parameter flow cytometry analysis of tumor infiltrating immune cells (Fortessa-X20\, Cytobank\, FlowJo\, FACS\, MACS).\nExpertise in in vivo pharmacology and experience with animal models of human cancers as well as strong publication record or evidence of equivalent achievements in industry are desired.\nHands on in vivo skills (IV\, PO dosing)\, blood/tissue collection\nProven ability to make important contributions to cancer biology\, immuno-oncology or related fields\nAbility to follow novel scientific or technological developments\, and to implement them in the laboratory.\nCurrent knowledge of oncology research\, drug discovery and development.\nExcellent written and oral communication and presentation skills in English.\nStrong ability to multi-task and work productively in a fast-paced\, highly collaborative\, and diverse team environment. Capability to contribute to a vivid and challenging intellectual environment.
URL:https://ces.b2sg.org/event/pfizer-21may18/
LOCATION:Pfizer – La Jolla\, CA\, 10350 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/pfizer_new_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180521
DTEND;VALUE=DATE:20180623
DTSTAMP:20260823T072202
CREATED:20180521T070643Z
LAST-MODIFIED:20180521T070753Z
UID:20149-1526860800-1529711999@ces.b2sg.org
SUMMARY:Computational Biologist
DESCRIPTION:Dr. Tim Triche Jr. is seeking a full-time Computational Biologist to join his research team. The Triche Lab focuses on developing statistical and mathematical methods to dissect pediatric and adult cancers\, with a focus on cancers of the blood in children. In pediatric tumors\, recurrent mutations alone are rarely sufficient to characterize a person’s disease\, and the role of inherited susceptibility is poorly understood. The lab seeks to improve both outcomes and quality of life by rational selection of positive (“Patients with X usually respond to A”) biomarkers for response and negative (“Patients with Y rarely respond to B”) biological markers for non-response over the course of disease. Particularly in rare tumors\, this approach is well suited to rapidly piloting clinical trials and re-purposing existing drugs; indeed\, one such regional DNA methylation marker is currently in a Phase III trial for front-line chemotherapy. \nWe collaborate broadly with clinical and basic scientists. The role of chromatin- and DNA-modifying proteins\, under the catchall term epigenetic regulators\, is a primary interest. Recent work characterizing genetic influences on transcription suggests that rare variants dominate the landscape\, motivating an alternate readout of regulatory aberrations. We are developing methods to improve both variant prioritization and interpretation of regulatory impacts by jointly analyzing both. To do so\, we make heavy use of high-throughput sequence analysis\, both in bulk and sorted cells\, often from clinical trials. \nOurs is a young lab. You will help determine its growth and direction\, and it will help determine yours. \nIn this role\, you will be responsible for the following tasks: \n\nHandle data management and reproducible analysis for a variety of experimental designs\nDevelop\, maintain\, and support computational biology pipelines\nPerform data mining at scale on both local and (where feasible) cloud pilot resources\nPre-print and publish results and novel methods\, serving as primary or contributing author\, while ensuring compliance with data sharing plans\, and wherever possible\, unsupervised replication\nAnticipate and keep abreast of new developments in bioinformatics and works to ensure the availability of state-of-the-art methods\, resources\, and data sources to support the user groups\nPerform other related duties as assigned (to include wet protocols if suited to the candidate)\n\n\nThis list will likely change as projects evolve and you must be open-minded to learn new things. \nExpectations: \nThe following expectations should be met within the first 3 months. \n\n1 month – Develop solid understanding of at least one major collaborative project\, adapt to VAI computing resources\, and demonstrate analytical reproducibility\, supervised by a senior collaborator\n3 months – Acquire significant data\, prepare informative summaries of interim analyses\, and take over both maintenance and development of analytical pipelines from our senior collaborators.\n\n\nQualifications: \nYou will possess a Master’s degree in computational biology\, bioinformatics\, mathematics\, statistics\, computer science\, or other relevant discipline (a BS with experience will be considered). \nThe ideal candidate \n\nHas working knowledge of at least one scripting language (e.g. R) and systems language (e.g. C)\nHas substantial experience with the analysis of next generation sequencing data (e.g. RNAseq)\nHas experience\, or interest in gaining experience\, with data integration (e.g. ATAC\, WGBS\, Hi-C)\nHas an understanding of cancer biology or genetics; this is helpful but not absolutely required.\nMay see this position as an ideal launching point for further graduate or clinical studies.\nHas a commitment to open\, collegial\, reproducible science\, and the betterment of society.\n\n\nIf you possess these attributes and desire to help us drive science from the bench to the clinic\, while benefiting from a highly generous compensation package; we would welcome speaking with you and encourage you to apply today.
URL:https://ces.b2sg.org/event/vari-21may18/
LOCATION:Van Adel Research Institute\, Grand Rapids\, MI\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/12/van-andel-research-inst-vari-vanandel.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180522
DTEND;VALUE=DATE:20180624
DTSTAMP:20260823T072202
CREATED:20180522T110717Z
LAST-MODIFIED:20180522T110717Z
UID:20209-1526947200-1529798399@ces.b2sg.org
SUMMARY:Research Fellow
DESCRIPTION:A Research Fellow position is available in the program of Dr. Keith Robertson. For more information about Dr. Robertson’s program\, please see: http://www.mayo.edu/research/faculty/robertson-keith-d-ph-d/bio-20035097 \nThe successful candidate will join the Epigenetic Etiology of Human Disease Laboratory to study the role of DNA epigenetic modifications in human disease. More specifically\, he/she will examine how DNA methylating and hydroxymethylating enzymes regulate their respective DNA epigenetic modifications and how these marks modulate expression and genome stability\, and interface with other epigenetic modifications. Disease focus areas of the laboratory include cancer (hepatocellular and renal)\, obesity\, and diabetes. Specific research areas include application of genome-wide epigenomics methods to decipher DNA methylation/hydroxymethylation defects in cancer and biochemical/cell culture-based techniques to study the regulation and interactions between chromatin remodeling factors (e.g. DNMTs\, TETs\, HMTases) and the roles of their target loci in driving disease. Techniques commonly used in the laboratory include: quantitative RT-PCR\, western blotting\, cell culture\, transfections\, bisulfite sequencing\, DNA immunoprecipitation\, pyrosequencing\, ChIP-qPCR\, ChIP-seq\, next-gen library preparation and sequencing\, Infinium 850k arrays\, bioinformatics analysis\, microscopy\, and biochemical analysis of protein function. Experience in one or more of these areas is a plus. The candidate will play a major role in the preparation of manuscripts that arise from this work and devote 100% effort to these tasks (no patient contact or other responsibilities). \nPosition description \nA Research Fellow at Mayo Clinic is a temporary position intended to provide training and education in research. Individuals will train in the research program of a Mayo Clinic principal investigator. Qualified individuals will demonstrate the potential for research as evidenced by their training and peer-reviewed publications and should become competitive for national research grants. Proof of English proficiency is required for J-1 Short-Term Scholars\, Research Scholars\, Professors\, Specialists\, and Student Interns sponsored by Mayo Clinic. 800146; J2WRTP \nQualifications \nMust have a Ph.D.\, M.D.\, or equivalent doctoral degree in a field deemed relevant by the program. Research Fellow is appropriate for individuals who have completed no more than one prior postdoctoral fellowship\, at Mayo Clinic or elsewhere.
URL:https://ces.b2sg.org/event/mayo-22may18/
LOCATION:Mayo Clinic\, 200 1st St SW\, Rochester\, MN\, 55905\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/mayo-clinic_416x416.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180522
DTEND;VALUE=DATE:20180624
DTSTAMP:20260823T072202
CREATED:20180522T111743Z
LAST-MODIFIED:20180522T112043Z
UID:20211-1526947200-1529798399@ces.b2sg.org
SUMMARY:ASSOCIATE SCIENTIST - CANCER IMMUNOLOGY
DESCRIPTION:Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. Neon utilizes its expertise in bioinformatics\, neoepitope prediction and immune monitoring to identify tumor specific mutations and monitor clinical response to their personalized vaccines. Neon Therapeutics’ lead program is NEO-PV-01\, a bespoke neoantigen vaccine that builds upon years of research and development at the Broad Institute and Dana-Farber Cancer Institute. NEO-PV-01 is now being studied in a Phase 1b clinical trial combining the vaccine with Opdivo®\, a PD-1 immune checkpoint inhibitor from Bristol-Myers Squibb\, in patients with measurable metastatic melanoma\, non-small cell lung cancer and bladder cancer. Three additional clinical trials are planned for 2018. Also in development are NEO-PTC-01\, a bespoke autologous T cell therapy\, and NEON / SELECT\, a Shared Neoantigen Program leveraging neoepitopes that are common across patients and tumor types.\nIn addition\, Neon has established strategic partners in BMS\, Merck\, and Apexigen to harness opportunities for combination therapies. Neon leverages foundational intellectual property from the Broad Institute and the Dana-Farber Cancer Institute.Neon Therapeutics was incubated and launched by Third Rock Ventures and raised a $55M Series A in 2015 and\, more recently\, a $106M Series B in 2017. \n\nPosition Summary \nThe successful candidate will work in the Neon SELECT program that aims to develop therapies against neoantigen targets shared across patients. S/he will focus on generating and studying T cell responses to shared neoantigens\, with particular focus on peptide design and T cell receptor characterization. The candidate will need to work on a team but also independently test many different technologies. S/he will need to work effectively on a team while also independently perform cell and molecular biology assays. The candidate will work closely with the departments of T cell immunology\, molecular immunology\, peptide chemistry\, and bioinformatics. \nJob Responsibilities: \n\nCulture and manipulation of human T cells\nAssessment and analysis of specificity of human T cells by multicolor flow cytometry\nPerform scRNA and TCR sequencing as well as data analysis\nDesign and analysis of immunogenic peptide sequences\nProduction of stable cell lines using transfection or transduction\nAnalysis and presentation of results to larger scientific groups\nAssist with the training of lab personnel\nWork productively in a team environment and independently and deliver against timelines.\n\nExperience and essential skills: \n\nM.S. with 5-8 years of experience\, or Ph.D. with 0-2 years of experience in industry with a strong background in immunology.\nA strong background in adaptive immunity in the context of cancer is preferred\nDemonstrated mastery of flow cytometry and related data analysis\nExperience with functional immune assays\, such as cytokine analysis\nGeneral molecular biology techniques\, including plasmid cloning and preparation\nExperience with lentivirus preparation and infection\nAbility to organize and tabulate data.\nStrong evidence of leadership background and experience working in cross-functional teams\nExcellent and record-keeping skills.\nStrong written and oral communication skills.\nIndependent\, flexible\, self-motivated.\n\n\nTo apply\, please send your resume to careers@neontherapeutics.com
URL:https://ces.b2sg.org/event/neon-22may18/
LOCATION:Neon Therapeutics\, 40 Erie St\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/Neon-logo-e1526988012112.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180523
DTEND;VALUE=DATE:20180625
DTSTAMP:20260823T072202
CREATED:20180523T160122Z
LAST-MODIFIED:20180523T160122Z
UID:20231-1527033600-1529884799@ces.b2sg.org
SUMMARY:Postdoctoral Research Fellow
DESCRIPTION:Receive training in specific area(s) of research with the aim of progressing towards an independent career. The appointment is for one year up to a usual maximum of three to four years\, each year contingent upon satisfactory progress\, as evaluated by the supervisor/mentor. \nKey Responsibilities: \n– Receive training in specific area(s) to continue the development of personal technical knowledge and research expertise.\n– Under guidance\, design\, plan and execute original research projects or major parts thereof.\n– Develop ability to critically evaluate and analyze data.\n– Keep a careful record of experiments in laboratory notebooks.\n– Publish and present data internally and externally.\n– Assist other institute researchers in areas of personal expertise.\n– Attend and participate in institutional programs\, seminars and lectures.\n– Progress towards an independent career.\n– Encouraged to seek outside training support.\n– Provide other related duties as required \nEducation: \n      PhD in relevant field of study \nPlease complete application and submit CV to be considered for this position.
URL:https://ces.b2sg.org/event/buck-23may18/
LOCATION:Buck Institute\, 8001 Redwood Boulevard\, Novato\, CA\, 94945\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/buck-institute-of-anti-aging-logo-1-e1506278436891.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180523
DTEND;VALUE=DATE:20180625
DTSTAMP:20260823T072202
CREATED:20180523T161745Z
LAST-MODIFIED:20180523T161759Z
UID:20234-1527033600-1529884799@ces.b2sg.org
SUMMARY:
DESCRIPTION:Education: Ph.D. in molecular biology\, biochemistry\, or related field with preferred dissertation research on human or mammalian epigenetics; alternately\, M.S. plus at least five years of experience in a related field \nYears of experience: Ph.D. – At least one year of postdoctoral research in a demonstrably relevant area; M.S. – at least five years of experience \nRequired Skills: \n\nExtensive experience identifying epigenetic signatures resulting from pathology (such as viral infection or cancer)\nExperience with high-throughput assays for identifying epigenetic modifications (e.g.\, next-gen sequencing\, microarrays\, pyrosequencing\, etc.)\nDemonstrated experience analyzing genome-wide methylation profiling or chromatin remodeling\nKnowledge of virology or other infectious disease models strongly preferred\nStrong oral\, written\, and interpersonal communication skills and abilities;\nDemonstrated time management and completion of tasks to a definite deadline\nBioinformatics experience (e.g.\, experience working in a Linux environment and common scripting languages) is desirable\nCandidates must be willing to submit and be eligible for a DoD secret clearance (i.e.\, must be subject to and pass a background investigation and must be a U.S. citizen).\nMust be able to do extended deskwork at a computer\nMust be able to stand for several hours at a time to perform lab work\nMust be able to wear standard PPE (e.g.\, mask\, gloves\, lab coat) for extended periods of time\n\n\nPrimary Responsibilities: \n\nLead efforts based on the identification of epigenetic biomarkers of exposure to biological and chemical pathogens. Support experimental design\, development and optimization of biomarker identification methods and workflows\, and data analysis to validate prospective markers.\nLead and/or support technical tasks or projects within a collaborative teaming environment. The Epigenetics Specialist will work within a team of molecular biologists\, forensic scientists\, biochemists\, bioinformaticians\, database managers\, statisticians\, and project managers to provide solutions to maximize the utility\, confidence\, and rapid reporting of results for large epigenetic datasets.\nSupport projects through employing efficient and accurate data evaluation techniques\, placing levels of statistical confidence on data output\, and clearly reporting results.\nInteract with clients (on and off-site) and present technical data through presentations and report writing.\nSupport end user trainings and client interactions.\nHelp grow the biological sciences business area through the successful and timely execution of projects\, positive interactions with clients\, recognition of opportunities for follow-on work with existing clients\, establishment of new opportunities with alternate clients\, proposal development and writing support\, and maintaining a presence at marketing and business development meetings/conferences.\nTravel to project and business development meetings as needed.\nReport directly to the biology Business Area Manager under the advisement of the Director of Biological Sciences.
URL:https://ces.b2sg.org/event/signature-23may18/
LOCATION:Signature Science LLC
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/12/Signature-Science-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180524
DTEND;VALUE=DATE:20180626
DTSTAMP:20260823T072202
CREATED:20180524T145813Z
LAST-MODIFIED:20180524T145927Z
UID:20250-1527120000-1529971199@ces.b2sg.org
SUMMARY:Research Associate
DESCRIPTION:To enable Guardant Health to lead the disruption of cancer treatments through non-invasive cancer screening\, the Technology Development Team is seeking a highly motivated Research Associate to help develop\, test\, and improve sample preparation technologies for rare variant and epigenetic studies with next-generation sequencing. At Guardant\, we leverage the most advanced technologies and work with leaders in many different fields to create the most impactful and meaningful technologies for cancer management. \nAs a Research Associate supporting product and technology development\, you will work with members within the team and interface with multiple teams including process engineering\, clinical operations\, research operations\, and bioinformatics. You will be hands on in the lab and be required to design\, implement\, and validate new technologies related to liquid biopsy sequencing assays for the early detection\, treatment\, and monitoring of all cancer types. \n\nOperate next generation sequencing instruments\nRun sequencing sample preparation assays in medium to high throughput environment\nTest and improve new sequencing sample preparation assays\nLog and track research samples throughout sequencing workflow\nMaintain appropriate inventory of lab supplies\nBring a can-do attitude to solve new and challenging problems in a high pace environment\nAnalyze data and troubleshoot issues within the tech dev team and among other teams\nCollaborate with all functions within project teams\nEngage in early design of products and perform experiments both independently and under the supervision of Senior team members within Tech Dev and Bioinformatics groups\nCan present updates\, write reports and SOPs\, and contribute to technical discussions\n\n\n\nQualifications \n\nThe ability to handle biological samples (i.e. tissue\, bio-fluid\, etc.) is a must\nExcellent written and oral communication skills is a must\nProfessional hands-on experience in industrial setting in genomics field is a plus (operational experience is preferred)\nHands-on experience in running sequencing platforms and assays is a plus
URL:https://ces.b2sg.org/event/guardant-24may18/
LOCATION:Guardant Health\, 505 Penobscot Dr.\, Redwood City\, CA\, 94063\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/guardant-health.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180524
DTEND;VALUE=DATE:20180626
DTSTAMP:20260823T072202
CREATED:20180524T150953Z
LAST-MODIFIED:20180524T150953Z
UID:20253-1527120000-1529971199@ces.b2sg.org
SUMMARY:Principal Research Scientist
DESCRIPTION:The Principal Research Scientist applies extensive biology and drug development expertise to oversee cross- functional research teams that are tasked with identifying and validating novel oncology targets\, and then apply deep biology insights to then translate these finding to position novel oncology therapeutic agents in contexts that maximally benefit patients.  \nThe mission of The Center for Co-Clinical Trials (CCCT) is to integrate biological insights with drug discovery expertise to accelerate the development of innovative targeted cancer therapeutics. The CCCT is a ground-breaking translational research team that partners with world-class drug discovery scientists at the Institute for Applied Cancer Science (IACS) along with their industry-modelled in vivo pharmacology unit and state-of-the-art computational biology infrastructure. CCCT’s cross- functional teams aim to deliver biological insights regarding genetic and functional contributions that influence tumor response to novel therapeutic agents or regimens. As part of the MD Anderson Cancer Center Moon Shots initiative\, the capabilities of the CCCT\, in concert with IACS\, support the institution’s academic and clinical research programs to help us reach our goal of delivering safer\, more effective treatments to our patients.  \nSalary Range Min $129\,000- Mid $161\,000 – Max $193\,000  \nKEY FUNCTIONS:\n1.Principal Research Scientist applies expert knowledge of tumor biology in areas such as immune oncology\, oncogenic signaling\, metabolism\, epigenetics and/or DNA damage to enable target discovery\, validation and drug development.  \n2.Oversee and/or lead multiple cross- functional research drug discovery and development programs.  \n3.Lead collaborations with computational biologists utilizing patient-centric –omic databases to identify deregulated contexts that inform on target discovery\, target validation and translational biology efforts in defined tumor contexts.  \n4.Oversee the design\, execution\, analysis and interpretation of in vitro\, ex-vivo and in vivo experiments to validate targets\, optimize compound selection and explore therapeutic potential of drug targets.  \n5.Apply knowledge of pharmacology to enable in vivo assessment of chemical matter and establishment of pharmacodynamics\, pharmacokinetic and efficacy relationships.  \n6.Lead drug discovery biology efforts to enable selection of lead candidate molecules.  \n7.Apply expertise to lead the discovery\, validation and development of cell and molecular assays to define mechanism of action\, measure pharmacodynamic changes and select patient responder populations.  \n8.Lead program biology efforts to enable clinical positioning of developmental candidates.  \n9.Develop and lead strong collaborative relationships with internal and external groups.  \n10.Manage activity of direct reports and project teams.  \n11.Interpret\, present and report research findings at internal meetings and external scientific conferences.  \n12.Evidence of independent thinking and leadership skills are vital. Ability to work well under pressure and drive projects that impact critical timelines is essential  \nEducation  \nRequired: PhD in one of the natural sciences or related field or Medical degree.  \nExperience  \nRequired: Seven years experience of relevant research experience in lab.  \nIdeal Candidate will possess the following:\n1.MD or PhD with over 7 years of relevant post-degree experience in a pharmaceutical/biotech environment.  \n2.Evidence of utilization of cancer genomics to inform on target discovery\, validation and/or clinical positioning of development drug candidates.  \n3.Experience with genetic (ie RNAi and cDNAs) and pharmacological (i.e. small molecule inhibitors or antibodies) approaches to study target biology utilizing biochemistry\, cellular and molecular biology methods and assays to drive program biology.  \n4.Experience utilizing mouse models of cancer to enable target discovery\, validation\, drug development and/or translational biology.  \n5.Experience working with chemists\, in vitro and in vivo pharmacologists to develop and utilize assays in support of the development of small molecules for target validation and as part of lead optimization.  \n6.Extensive knowledge and experience in areas of tumor biology including\, but not limited to immune oncology\, oncogenic signaling\, cancer metabolism\, epigenetic deregulation\, apoptosis and/or DNA damage and repair as evidenced by publication in peer-reviewed journals.  \n7.Strong data analysis skills\, ability to interpret results\, design of follow-up experiments\, troubleshoot issues with assay performance\, and effectively present results and conclusions to co-workers\, collaborators and senior leadership.  \n8.Evidence of leading multi-functional teams of scientists to deliver on program objectives.  \n9.Evidence of independent thinking and leadership skills. 
URL:https://ces.b2sg.org/event/mda-24may18/
LOCATION:MD Anderson Cancer Center\, 1515 Holcombe Blvd\, Houston\, TX\, 77030\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/MDAnderson.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180525
DTEND;VALUE=DATE:20180627
DTSTAMP:20260823T072202
CREATED:20180525T084047Z
LAST-MODIFIED:20180525T084059Z
UID:20256-1527206400-1530057599@ces.b2sg.org
SUMMARY:Labratory Technican
DESCRIPTION:The Department of Medicine\, Division of Hematology/Oncology is looking to fill two OPS Lab Tech positions. The selected candidates will need to be highly motivated individuals to study epigenetic mechanisms in cancer. \nExperimental duties will include but not be limited to\, using molecular biology techniques such as cell culture\, western blotting\, Chromatin immunoprecipitation\, CRISPR/Cas9 gene editing and next generation sequencing (RNA-seq\, ChIP-seq) to test how structural and functional mutations in proteins that regulate chromatin structure may alter gene expression and promote the tumor phenotype. Additional duties associated with the position may include performing experiments in mice and assisting in the maintenance of the lab’s animal colony and occasional lab maintenance/housekeeping/ordering. Excellent written and oral English language skills are required. Prior experience with mouse models\, flow cytometry\, western blotting and PCR is preferred but not required. In addition\, it is essential that the candidate can work independently in the lab\, maintain an electronic lab notebook describing their research activity\, participate in lab meetings and display good interpersonal skills.
URL:https://ces.b2sg.org/event/uf-25may18/
LOCATION:University of Florida\, Gainesville\, FL\, 32611\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/uni-florida.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180525
DTEND;VALUE=DATE:20180627
DTSTAMP:20260823T072202
CREATED:20180525T093115Z
LAST-MODIFIED:20180525T093219Z
UID:20259-1527206400-1530057599@ces.b2sg.org
SUMMARY:Postdoctoral Associate - Functional Genetics of Cancer
DESCRIPTION:Our group is interested in the functional genetics of cancer. We use state of the art technology in genomics\, proteomics and epigenetics to understand the molecular mechanisms that drive cancer progression\, metastasis and chemoresistance. We are recruiting a postdoctoral fellow to work on understanding the functional consequences of combinations of mutations that contribute to tumorigenesis. Highly self-driven\, ambitious candidates with a knack for solving challenging problems in cancer biology and outstanding publication track record are encouraged to apply. The candidate is expected to work as a part of multi-disciplinary\, dynamic and vibrant team\, and will have the opportunity to work and develop his/her research program with the best in the field. \n  \nEducation and/or Experience: \nYou hold a PhD degree or equivalent in bioinformatics\, statistics\, computational biology\, or related discipline of biomedical research. Experience in computational and statistical genetics\, genomics and knowledge of R and PERL and their application in cancer research is mandatory. Programming experience is required as is having worked with big data. It is desired that you are familiar with standard molecular biology\, tissue culture practices and mouse genetics protocol. The successful candidate will have strong qualifications or experience within several of the following areas: \n\nBioinformatics and systems biology at the molecular level\nCancer pathophysiology and RNA biology of Cancer.\nProject management of interdisciplinary research projects within genomics and bioinformatics (Genomics\, Non-coding RNAs\, Proteomics and Chromatin Biology)\nExperience with data structures\, databases\, and data architectures (TCGA\, SU2C etc)\nKnowledge of biomedical resources and infrastructures
URL:https://ces.b2sg.org/event/sbp-25may18/
LOCATION:Sanford Burnham Prebys Medical Discovery Institute\, 10901 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/sanford-burham-sbp.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180527
DTEND;VALUE=DATE:20180629
DTSTAMP:20260823T072202
CREATED:20180527T131832Z
LAST-MODIFIED:20180527T132216Z
UID:20262-1527379200-1530230399@ces.b2sg.org
SUMMARY:Associate Research Scientist
DESCRIPTION:Apply On Company Site\n\n\n\n\nColumbia University invites applications for a molecular biologist appointment in the Department of Pathology and Cell Biology at the Columbia University Medical Center in Dr. Kevin Gardner’s Lab. Positions are available to study basic mechanisms of epigenetic gene regulation and transcriptional control in breast cancer. The lab has an integrated focus on fundamental mechanisms of chromatin-based transcriptional control\, including basic mechanisms of epigenetic regulation and enhancer function (Proc Natl Acad Sci U S A. 2009 Nov 17;106(46): 19286-91; Nat Struct Mol Biol. 2010 Dec;17(12): 1406-13; Nat Commun. 2012 Jan 17;3:633; Nat Commun. 2013;4:1449). New initiatives include the application of these methods and approaches to translational research to improve the diagnosis\, treatment and prevention of breast cancer. Central themes are understanding the role of transcriptional cross-talk and intersections receptor-mediated signaling pathways in the control of enhancer-mediated influence on gene expression. A major goal in the lab is the development omic perspectives that integrate next-generation sequencing with genomics\, transcriptomics\, epigenomics\, proteomics and metabolomics. The projects will be supported by access to an established diverse cohort of breast cancer patient samples with deep next generation molecular genomic characterization for both gene and pathway discovery and translation application in diagnosis\, treatment\, and prevention.  \nMinimum Degree Required:\n Ph.D. / M.D. or both  \nMinimum Qualifications:\n All applicants MUST meet these minimum qualifications to be considered for the position.  \nCandidate must have background in one or more our current research specialties: Cancer Biology\, Neurodegenerative diseases\, Cellular and molecular neurobiology\, Cell motility\, Cytoskeleton and intracellular trafficking\, Virology\, Molecular Biology\, Neuronal stem cells and Anatomic or Clinical pathology.  \nPreferred Qualifications:\n Ph.D. or M.D. equivalent in areas molecular biology or related field. Expertise in the construction sequencing libraries for various genomic analytical platforms including RNA-seq\, Exome-sequencing\, and ChIP-seq is required. Experience in the performance and analysis of ChIP-seq is required. Familiarity with CRISPR/Cas9 technology and ATTAC-seq analysis is highly desirable. An understanding of bioinformatic approaches and technologies in manipulating and interpreting deep sequencing data would be a significant advantage. We are looking for individuals with a strong desire to work on fundamental research questions in cancer and chromatin biology. Those candidates with a proven research experience and a history of an ability to independently drive a project forward in an interactive environment\, with willingness to provide mentorship to junior lab members\, would be highly competitive. 
URL:https://ces.b2sg.org/event/cu-27may18/
LOCATION:Columbia University Medical Center\, 630 W 168th St\, New York\, NY\, 10032\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/Columbia-University-Medical-Center.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180528
DTEND;VALUE=DATE:20180630
DTSTAMP:20260823T072202
CREATED:20180528T095714Z
LAST-MODIFIED:20180528T095806Z
UID:20265-1527465600-1530316799@ces.b2sg.org
SUMMARY:Assistant\, Associate or Full Professor - Cancer Biology
DESCRIPTION:The Department of Cancer Biology at the Perelman School of Medicine at the University of Pennsylvania seeks candidates for a Full\, Associate\, and/or Assistant Professor position in the tenure track. The successful applicant will have experience in the field of cancer biology\, including but not limited to tumor immunology\, chemical biology\, cancer metabolism\, cancer genetics and epigenetics\, cancer cell biology\, tumor microenvironment\, stem cells\, and metastasis. Responsibilities include maintenance of an externally funded independent research program\, as well as teaching and mentoring of students. Applicants must have an Ph.D. and/or M.D. degree and have demonstrated excellent qualifications in research and education. \nWe seek candidates who embrace and reflect diversity in the broadest sense. \nThe University of Pennsylvania is an EOE. Minorities/Women/Individuals with disabilities/Protected Veterans are encouraged to apply. \n\nApply for this position online at: https://www.med.upenn.edu/apps/faculty_ad/index.php/g/d4794
URL:https://ces.b2sg.org/event/upenn-28may18/
LOCATION:University of Pennsylvania\, 3400 Civic Center Blvd\, Philadelphia\, 19104\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/penn-1-e1494306554396.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180528
DTEND;VALUE=DATE:20180630
DTSTAMP:20260823T072202
CREATED:20180528T101708Z
LAST-MODIFIED:20180528T101708Z
UID:20269-1527465600-1530316799@ces.b2sg.org
SUMMARY:Faculty Position - Gene Regulation\, Genomics\, and Reproduction
DESCRIPTION:The Cecil H. and Ida Green Center for Reproductive Biology Sciences\, an endowed basic science research center within the University of Texas Southwestern Medical Center Department of Obstetrics and Gynecology\, is recruiting to fill a newly created Tenure-track Assistant Professor Position. We invite applications from outstanding candidates studying aspects of signaling\, gene regulation\, and genome function\, especially in the areas of chromatin and transcription\, epigenetics\, nuclear endpoints of cellular signaling pathways\, nuclear receptors\, RNA biology\, genome organization\, and genome evolution. We are interested in a wide variety of model systems and experimental approaches\, including biochemistry\, molecular biology\, structural biology\, animal models\, genetics\, genomics\, proteomics\, bioinformatics\, and computational biology. The Green Center’s research programs focus on\, but are not limited to\, reproduction and development in a broad sense\, as well as aspects of endocrinology\, stem cells\, cancer\, metabolism\, inflammation\, immunity\, and neurobiology. For this search\, we are particularly interested in recruiting a candidate who represents one or more of these areas of biology:\n\n\nSignaling\, chromatin\, and gene regulation\, using a wide array of experimental approaches to address fundamental questions in nuclear signaling\, chromatin\, transcription\, epigenetics\, and RNA biology.\n\n\nMolecular biology of female reproductive systems\, from stems cells\, oncogenesis\, and fertilization\, to implantation\, placental function\, pregnancy\, and parturition\, using cell-based or physiological models in combination with molecular or genomic approaches.\n\n\nGenomic\, bioinformatic\, computational\, and evolutionary approaches to understanding gene regulation\, using state-of-the-art genomic and computational tools.\n\n\nThe Green Center promotes and supports cutting-edge\, integrative\, and collaborative basic research in reproduction\, development\, and related areas of biology\, as well as strong connections between basic and clinical research. This recruitment is part of a major university and department-supported renovation and rejuvenation of The Green Center over the past 7 years. Successful candidates will be housed in a newly renovated state-of-the-art research facility and provided a generous start-up package\, and are expected to establish scientifically rigorous and externally funded research programs and participate in center\, department\, and university teaching and training programs. To learn more about The Green Center\, visit: \nhttp://www.utsouthwestern.edu/education/medical-school/departments/green-center/index.html \nCandidates must have a Ph.D. or M.D. or equivalent in a relevant field of study\, postdoctoral or comparable experience\, and a demonstrated record of research excellence. Applicants should send a letter of application\, curriculum vitae\, and a statement of planned research projects as pdf files to GreenCenter@UTSouthwestern.edu. Please indicate one of the three research areas listed above (Molecular biology of female reproduction; Gene regulation; Genomics) in the subject line of the email. Applicants should also arrange for three letters of reference to be sent directly to the above e-mail address. Review of applications will begin on October 30\, 2017\, and will continue during the 2017–2018 academic year or until the position is filled\, although applicants are encouraged to submit their materials as soon as possible.
URL:https://ces.b2sg.org/event/utsw-28may18/
LOCATION:UT Southwestern Medical Center\, 5323 Harry Hines Blvd.\, Dallas\, TX\, 75390\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/ut-southwestern-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180529
DTEND;VALUE=DATE:20180701
DTSTAMP:20260823T072202
CREATED:20180529T095017Z
LAST-MODIFIED:20180529T095017Z
UID:20271-1527552000-1530403199@ces.b2sg.org
SUMMARY:Faculty Positions (DOQ)
DESCRIPTION:Huntsman Cancer Institute (HCI) and the Department of Oncological Sciences at the University of Utah Health Sciences Center seeks outstanding candidates for faculty positions at all levels and at all ranks in basic and translational cancer research. \nHCI is an NCI-designated Comprehensive Cancer Center and a member of the National Comprehensive Cancer Network (NCCN)\, supporting and fostering a vibrant research enterprise in a highly collegial environment. HCI has a strong history of academic achievement and impact as well as a commitment to excellence in patient care\, research\, teaching and service. \nHCI has made a strategic commitment to develop disease-oriented research teams (DOTs) as a mechanism to enhance translational research. DOTs specialize in adult and pediatric cancer research in the following areas: Colon Cancer\, Genitourinary and Hematologic Malignancies\, Hepatobiliary Cancer\, Melanoma\, Neuro-Oncology\, Pancreatic Cancer\, Sarcoma\, Upper Aero Digestive Tract (with existing strengths in lung cancer) and Women’s Cancers. Candidates whose research interests are aligned with these DOTs are strongly encouraged to apply. \n1. Basic Cancer Research:\nWe seek junior and senior investigators with innovative research programs in cancer-relevant biology that emphasize mechanistic approaches. Areas of interest include signal transduction\, stem cells\, gene regulation & transcription\, chromatin & epigenetics\, genome stability & DNA repair\, metabolism\, cancer genetics\, metastasis\, epithelial biology\, tumor immunology\, hematologic malignancies\, pediatric/youth cancers\, and mechanisms of therapy resistance. \n2. Translational Cancer Research:\nThis broad-based recruitment seeks outstanding junior or senior investigators in areas including\, but not limited to: animal models\, signal transduction\, cancer genetics\, target validation\, drug discovery & validation\, epigenetics & gene expression\, DNA damage & repair\, tumor immunology\, cancer initiating cells\, and clinical cancer research. Candidates whose scientific interests will synergize with the clinical strengths of the HCI DOTs are particularly encouraged to apply. \nHCI and the University Health Sciences Center provide access to state-of-the-art equipment and services through exceptional Core Facilities (see www.cores.utah.edu) that enhance both discovery and translational science. HCI offers state-of-the-art laboratories\, including a new 225\,000 sq. ft. research building that doubles the Institute’s research space\, which opened summer 2017. The University of Utah offers excellent graduate programs for training PhD and MD/PhD students. For more information about HCI\, visit www.huntsmancancer.org. \nApplicants for Assistant Professor are expected to hold MD\, PhD\, or MD/PhD (or equivalent)\, have received appropriate postdoctoral training\, and to have a track record of impact and research productivity. Applicants for senior positions should additionally have a strong record of independent funding and innovative research. HCI particularly encourages and welcomes applications from physician-scientists across the continuum of cancer research. Highly competitive recruitment packages are available with appointment and rank in an academic department at the University of Utah determined by the applicants’ qualifications. \nCandidates should submit a curriculum vitae\, cover letter containing a description of professional experience (including scientific accomplishments\, leadership responsibilities and 3 references)\, and a 2-3 page research plan. Applications will be accepted continuously\, with evaluations beginning November 10\, 2017\, until positions are filled or closed. \nTo apply online\, please visit the following link:\nhttp://utah.peopleadmin.com/postings/69239 \nOr\, send to:\nHuntsman Cancer Institute\nAttn: Recruitment Office\, Room 5160\n2000 Circle of Hope\, Salt Lake City\, UT 84112-5550\nEmail: hci.recruitment@hci.utah.edu \nFor questions\, please contact Natalie Angle at hci.recruitment@hci.utah.edu
URL:https://ces.b2sg.org/event/utah-29may18/
LOCATION:University of Utah\, 201 Presidents Cir\, Salt Lake City\, 84112\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/university-of-utah_416x416.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180529
DTEND;VALUE=DATE:20180701
DTSTAMP:20260823T072202
CREATED:20180529T100715Z
LAST-MODIFIED:20180529T100715Z
UID:20273-1527552000-1530403199@ces.b2sg.org
SUMMARY:Post-Doctoral Fellow
DESCRIPTION:Post Doctoral Fellow positions (2) are available in laboratory of Dr. Kavitha Sarma at The Wistar Institute\, member of Penn Epigenetics Institute in Philadelphia.  Candidates must be highly motivated\, enthusiastic and interactive scientists with interests in gene regulation\, chromatin biology and epigenetics. A strong background in molecular biology and protein biochemistry and experience in mammalian cell culture is required.  Candidates with experience in RNA-Seq and ChIP-Seq technologies are preferred. \n\nCandidates should have a PhD degree and must have at least one first author peer reviewed publication. Application must include the following documents: \n\n\nA CV including a list of publications\, manuscripts in preparation\, and technical skills.\nOne-page cover letter stating reasons for their scientific interest in the lab and career goals.\nNames and contact information for at least 3 references to ksarma@wistar.org.
URL:https://ces.b2sg.org/event/wistar-29may18/
LOCATION:Wistar Institute\, 3601 Spruce Street\, Philadelphia\, PA\, 19104\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/07/wistar-inst.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180530
DTEND;VALUE=DATE:20180702
DTSTAMP:20260823T072202
CREATED:20180530T105455Z
LAST-MODIFIED:20180530T105455Z
UID:20299-1527638400-1530489599@ces.b2sg.org
SUMMARY:Research Laboratory Technician
DESCRIPTION:A Research Laboratory Technician position is available to work on brain tumors research. Working independently under the direction of the Principal Investigator Dr. Mario Suvà in the research laboratory within the Department of Pathology\, MGH\, the Research Technician II is required to develop and successfully implement various new technologies and coordinate computational data analysis.\nPRINCIPAL DUTIES AND RESPONSIBILITIES:\nThe principle responsibility of the technician is to carry out the technical aspects of molecular testing and cancer epigenetics in gliomas\, with the guidance of the PI. The specific responsibilities include:\n· Performing technical components of molecular assays\, including\, but not limited to\, the development\, testing\, and analysis of next-generation sequencing. The laboratory is developing two technologies applied directly to patient tumors: single cell RNA- sequencing and epigenomic profiling by chromatin-immunoprecipitation\n· Derivation of short-term primary cultures from patient tumors\n· Perform functional genes knock-out using novel genome-editing technologies such as the CRISPR/cas9 system. Perform in vitro drug treatment of primary cancer cell lines\, and analysis of cell responses using immunohistochemistry and western blotting\n· Ensuring specimen integrity\n· Routine lab tasks including glassware cleaning and equipment maintenance and QC programs (on a shared schedule)\n· Ensuring patient privacy and compliance with HIPAA guidelines\n· Maintaining and updating the Research laboratory manual in accordance with the regulations\n· Education of residents\, fellows\, medical students and technicians\n· Work in a collaborative fashion with other group members\n· Manages orders for the lab\nSKILLS/ABILITIES/COMPETENCIES REQUIRED :\n\nExcellent communication skills\, both oral and written.\nAbility to identify problems and develop solutions.\nFamiliarity with molecular biology\, computers and the metric system.\nKnowledge of next-generation sequencing.\nFamiliarity and understanding of the concepts of molarity\, normality\, molecular weight\, formula weight of chemicals.\nMust be familiar with how to make dilutions from stock solutions.\nKnowledge of good laboratory techniques and the scientific method.\nAbility to do mathematical calculations.\nMust know the proper handling procedure of chemicals and sterile tissue culture technique.\nAbility to prioritize\, work within deadlines and multi-task.\nHigh degree of computer literacy.\n\n\n\nQualifications\nEDUCATION:\nBA/BS degree in Biological or Physical Sciences required.\nEXPERIENCE :\nA minimum of 1-2yrs of directly related and progressively more responsible experience.\nPrevious experience in epigenomic profiling and RNA-sequencing is required.
URL:https://ces.b2sg.org/event/mgh-30may18/
LOCATION:Massachusetts General Hospital Cancer Cente\, 55 Fruit St\, Boston\, MA\, 02114\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/mgh-massachusetts-general-hospital-cancer-center.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180601
DTEND;VALUE=DATE:20180606
DTSTAMP:20260823T072202
CREATED:20180510T181359Z
LAST-MODIFIED:20180510T181520Z
UID:20042-1527811200-1528243199@ces.b2sg.org
SUMMARY:ASCO Annual Meeting
DESCRIPTION:The Annual Meeting brings together more than 32\,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities\, new therapies\, and ongoing controversies in the field. \n\n\n\n\n\n\nWe can’t wait to see you in Chicago. As you prepare for this year’s Meeting\, visit the Attendee Resource Center to find a host of resources that will help simplify your experience. Also\, check out pre-meeting educational programs and networking meet-ups and networking lounges designed to help attendees make the most out of their meeting. \n\n\n\nSESSION TYPES\n \n\n\n\n\n\n\n\n\nEducation Sessions\nEducation Sessions offer interdisciplinary or multidisciplinary explorations of focused areas of clinical oncology. ASCO’s Cancer Education Committee determines the topics and format for these sessions that will best serve the educational needs of Annual Meeting attendees. Particular care is taken to ensure that these sessions address issues including surgical\, radiation\, and geriatric oncology; symptom management; health services research; international perspectives; and pathology\, as appropriate. \nClinical Problems in Oncology Sessions\nClinical Problems in Oncology Sessions combine the use of case-based panel discussion with interactive keypad technology for audience participation. These sessions are ticketed and require an additional registration fee. \nMeet the Professor Sessions\nMeet the Professor Sessions enable interactive discussion between attendees and recognized experts in a variety of subspecialty fields. The format is informal with an emphasis on a face-to-face exchange with the expert. These sessions are ticketed and require an additional registration fee. \nWorkshops\nNew in 2018: ASCO Annual Meeting Workshops will offer interactive\, didactic teaching to attendees on select topics. Attendees will participate in hands-on experiences\, working in small groups to learn practical\, take-home skills and tools to implement in their practices. Workshops are scheduled for Friday\, June 1\, and will be limited in size. Space will be available on a first come\, first served basis.  \nPlenary Session\nThe Plenary Session includes 15-minute didactic presentations highlighting abstracts of scientific research deemed to have the highest merit and greatest impact on oncology research and practice. Experts in the field will serve as discussants to place research findings into perspective. The Plenary Session will take place on June 3\, 2018\, 1:00 PM-4:00 PM. \nOral Abstract Sessions\nOral Abstract Sessions include didactic presentations of abstracts representing important clinical and translational research findings by topic category. Presenting authors may use PowerPoint slides to accompany their oral presentation. Experts in the field are chosen as discussants to provide comprehensive themed discussions of the findings from predetermined abstracts. \nClinical Science Symposia\nClinical Science Symposia provide a forum for science in oncology\, providing foundational education on a specific topic with the presentation of abstracts. Experts in the field (discussants) place studies in the appropriate context based on the strength of the evidence and critically discuss the conclusions in terms of their applicability to clinical practice. \nHighlights of the Day Sessions\nHighlights of the Day Sessions invite expert discussants to present key findings\, put abstracts into clinical context\, and provide an overview of the previous day’s oral abstract sessions. \nPoster and Poster Discussion Sessions\nAbstracts displayed in poster format. Select posters will be chosen for Poster Discussion Sessions where expert discussants will highlight the most clinically applicable and novel posters\, with abstract authors participating as panel members. These sessions will be followed by networking with discussants and authors. \nAward Lectures\nPresented throughout the Annual Meeting\, Award Lectures recognize distinguished award recipients. \nAnnual Business Meeting\nThe ASCO Annual Business Meeting is for ASCO Members to hear updates on the state of the Society.  Members are encouraged to pre-register online to attend this event. \nOpening Session\nThe Opening Session includes the Presidential Address\, Guest Speaker’s Address\, and recognition of Fellows of the American Society of Clinical Oncology (FASCO).
URL:https://ces.b2sg.org/event/asco-1jun18/
LOCATION:ASCO 2018\, McCormick Place\, Chicago\, IL\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/asco.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180601
DTEND;VALUE=DATE:20180702
DTSTAMP:20260823T072202
CREATED:20180601T072518Z
LAST-MODIFIED:20180601T072518Z
UID:20324-1527811200-1530489599@ces.b2sg.org
SUMMARY:Postdoctoral Associate
DESCRIPTION:An exciting opportunity is available to join a cancer pharmacology lab that emphasizes pharmacokinetic (PK)\, pharmacodynamic (PD)\, and quantitative systems pharmacology (QSP) approaches to study brain tumors. The lab integrates experimental data with mathematical models or QSP models to characterize drug action and predict drug responses in patients. The ultimate goal is to bridge preclinical and clinical drug development paradigms and advance precision medicine. \nThe postdoctoral position is in the lab of James M. Gallo in the Department of Pharmaceutical Sciences\, School of Pharmacy and Pharmaceutical Sciences at the University at Buffalo. The department is a premier research unit with a storied tradition of excellence in PK/PD research. Ongoing projects are in anticancer drug development\, drug resistance\, cell state\, epigenetics and tumor heterogeneity. \nThe postdoctoral associate will join a highly interactive department with a central focus of PK/PD/QSP modeling\, and have opportunities to interact with highly talented graduate students\, and scientists within the university including Roswell Park Cancer Institute. Position responsibilities include: \n• Develop PK/PD/QSP models using a variety of computer programs.\n• Participate in lab meetings and contribute to the training of students and lab personnel in advanced modeling methods.\n• Interact positively with scientific personnel across different disciplines to advance QSP.\n• Provide expert support of computer systems used for the labs modeling efforts. \n• Maintain abreast of current literature in the fields relevant to lab projects.\n• Provide reports based on your work for scientific publications and extramural funding applications.\n• Advance your knowledge of QSP modeling methods and implement those as needed \n\nMinimum Qualifications: \n• Ph.D. in Engineering\, Mathematics\, Pharmacometrics\, Systems Biology/Pharmacology or a related field.\n• Demonstration of mathematical modeling & computer simulation experience; preferably related to biomedical/pharmaceutical applications. \n• Expertise in Matlab/SimBiology/Simulink. \n• Additional familiarity with R\, JDesigner/Systems Biology Workbench and related programs desirable.
URL:https://ces.b2sg.org/event/ub-1jun18/
LOCATION:University at Buffalo\, Buffalo\, NY\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/ub-uni-at-buffalo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180601
DTEND;VALUE=DATE:20180703
DTSTAMP:20260823T072202
CREATED:20180601T100340Z
LAST-MODIFIED:20180601T100440Z
UID:20326-1527811200-1530575999@ces.b2sg.org
SUMMARY:Postdoctoral Associate
DESCRIPTION:We are seeking a highly motivated Postdoctoral Associate to join the newly established Agarwal lab at Texas Children’s Cancer Center and the Department of Pediatrics\, Baylor College of Medicine. This position will assist the PI in performing complex research experiments\, handling the mouse colony\, drafting manuscripts\, and to upkeep the laboratory. \n\nImplement flow cytometry based assays\nCloning\nLaboratory experiments including MTT assays\, soft agar assays\, Western Immunoblotting\, PCR and q-PCR\nUpkeep of laboratory and equipments\nTrain junior laboratory personnel\nAssist the PI in experiments\nManuscript preparation\n\nRequired: Recent PhD with experience and interest in molecular oncology and epigenetics. \n\nIdeally\, the candidate should have prior experience and comfort in handling and maintaining mouse colony\, xenograft tumor assays\, mouse imaging\, mouse tissue extraction and molecular analysis.\nExcellent communication skills\, research ethics\, laboratory record keeping\, and data analytic skills are required.
URL:https://ces.b2sg.org/event/bcm-1jun18/
LOCATION:Baylor College of Medicine\, 1 Baylor Plaza\, Houston\, TX\, 77030\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/bcm-baylor-e1494304823632.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180602
DTEND;VALUE=DATE:20180704
DTSTAMP:20260823T072202
CREATED:20180602T194956Z
LAST-MODIFIED:20180602T194956Z
UID:20331-1527897600-1530662399@ces.b2sg.org
SUMMARY:Cancer Faculty Investigators
DESCRIPTION:The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center (CCC) is leading the recruitment of multiple investigators (up to 15) for a major strategic increase in its portfolio across basic and translational research efforts. Recruitment is for tenured\, tenure-track\, and non-tenure-earning faculty at all ranks and includes academic appointment in one or more of 27 academic departments across the School of Medicine (SOM)\, many of which rank in the top 10 nationally in NIH funding. All applications will be considered\, but priority will be given to those with emphasis (or focused) in: tumor immunology and inflammation\, cancer cell metabolism\, epigenetics\, oncolytic viruses\, cancer outcomes and survivorship\, role of the microbiome in cancer\, cancer imaging\, chemoprevention and informatics. Likewise\, we are interested in research involving the following organ systems: ovary\, breast\, lung\, GU\, GI\, brain and hematologic malignancies including multiple myeloma. \nDriven by an intensely collaborative and entrepreneurial character\, UAB is one of the leading economic engines of the State\, with a nearly $4 billion budget and a statewide economic impact exceeding $7 billion annually. UAB is Alabama’s largest employer with more than 23\,000 employees; it supports more than 64\,000 jobs statewide. With more than 1\,300 full time faculty and almost 1\,200 medical and graduate students\, the UAB SOM ranks 23rd nationally in NIH research funding and in the top 10 for all public institutions. Total research expenditures at UAB exceeded $538 million in 2017. \nSuccessful applicants will join one of the most prestigious comprehensive cancer centers in the country. The UAB CCC was one of the first eight NCI-designated Cancer Centers in 1972 and has been continuously funded for 46 years. It is the only CCC in a four-state region in the Deep South. The UAB CCC treats over 5\,000 new cancer patients annually and has an extensive effort focused on delivering cancer care and conducting research in underserved populations. The UAB CCC has over 400 members conducting outstanding cancer research in six scientific programs. Center members receive approximately $100 million in extramural cancer research funds annually\, including multiple program project and large “team science” grants. The UAB CCC has 12 grant-supported cores\, 9 of which are institutional shared resource facilities. A robust clinical trial infrastructure currently supports nearly 200 cancer clinical trials. UAB is one of 42 institutions with an NIH Clinical and Translational Science Award\, which supports translational research and creates a supportive environment that synergizes with the UAB CCC to promote junior investigators. \nApplicants must upload their Curriculum Vitae\, one page letter of interest\, and 3 professional references to http://uab.peopleadmin.com/postings/4116. Application deadline is July 15\, 2018. Review of applications will continue until all positions are filled. Applicants must have an MD\, PhD or MD/PhD. Selected applicants will join a diverse and vibrant academic community that values and is committed to diversity\, equity and inclusion and must be able to work in a team environment.
URL:https://ces.b2sg.org/event/uab-2jun18/
LOCATION:University of Alabama at Birmingham\, 1801 University Blvd\, Birmingham\, AL\, 35233\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/06/uab-University-of-Alabama-at-Birmingham.jpg
END:VEVENT
END:VCALENDAR